Publications by authors named "Danielle Roman"

Claim this Profile
D
Discovery, Preclinical Characterization, and Early Clinical Activity of JDQ443, a Structurally Novel, Potent, and Selective Covalent Oral Inhibitor of KRASG12C.
Andreas Weiss, Edwige Lorthiois, Louise Barys, Kim S Beyer, Claudio Bomio-Confaglia, Danielle Roman

Cancer Discov· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASHP-HOPA guidelines on the roles and responsibilities of the pharmacy technician in ambulatory oncology pharmacy.
Jason Bergsbaken, Danielle Roman, Marc A Earl, Ali McBride, Jacqueline L Olin

Am J Health Syst Pharm· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential Obstacles in the Acquisition of Oral Anticancer Medications.
Jennifer L Niccolai, Danielle L Roman, Justin M Julius, Rachelle W Nadour

J Oncol Pract· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular toxicity of AUY922 in pigmented and albino rats.
Danielle Roman, James VerHoeve, Heiko Schadt, Axel Vicart, Ursula Junker Walker

Toxicol Appl Pharmacol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vemurafenib: First-in-Class BRAF-Mutated Inhibitor for the Treatment of Unresectable or Metastatic Melanoma.
Lindsay Shelledy, Danielle Roman

J Adv Pract Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regorafenib: Adding to the Armamentarium for Refractory Colorectal Cancer and GIST.
Danielle Roman, Rachelle Whiteside

J Adv Pract Oncol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of potential nilotinib cardiotoxicity.
Armin Wolf, Philippe Couttet, Min Dong, Olivier Grenet, Marcia Heron, Danielle Roman

Leuk Res· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imatinib does not induce cardiotoxicity at clinically relevant concentrations in preclinical studies.
Armin Wolf, Philippe Couttet, Min Dong, Olivier Grenet, Marcia Heron, Danielle Roman

Leuk Res· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiglaucoma drug GLC756 and its effect on cellular cAMP and tumor necrosis factor alpha release in vitro of activated human monocytic leukemia cells.
Ulrich W Laengle, Rudolf Markstein, Cecile Cazaubon, Danielle Roman

Jpn J Ophthalmol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of latanoprost, timolol and GLC756, a novel dopamine D(2) agonist and D(1) antagonist on LTC(4) release after rat mast cell activation.
Ulrich W Laengle, Rudolf Markstein, Dominique Pralet, Wolfgang Seewald, Danielle Roman

Clin Exp Ophthalmol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of GLC756, a novel mixed dopamine D1 receptor antagonist and dopamine D2 receptor agonist, on TNF-alpha release in vitro from activated rat mast cells.
Ulrich Wilhelm Laengle, Rudolf Markstein, Dominique Pralet, Wolfgang Seewald, Danielle Roman

Exp Eye Res· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLC756 decreases TNF-alpha via an alpha2 and beta2 adrenoceptor related mechanism.
Ulrich W Laengle, Anne U Trendelenburg, Rudolf Markstein, Vicente Nogues, Anne Provencher-Bollinger, Danielle Roman

Exp Eye Res· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The minipig in dermatotoxicology: methods and challenges.
Jörg Andreas Mahl, Beate E Vogel, Mireille Court, Maryelle Kolopp, Danielle Roman

Exp Toxicol Pathol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of antiglaucoma drugs timolol and GLC756, a novel dopamine D2 agonist and D1 antagonist, on endotoxin-induced-uveitis in rats.
Ulrich Wilhelm Laengle, Rudolf Markstein, Verena Schneider, Brigitte Greiner, Danielle Roman

Exp Eye Res· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LAV694, a new antiproliferative agent showing improved skin tolerability vs. clinical standards for the treatment of actinic keratosis.
Jesús Medina, Valérie Picarles, Brigitte Greiner, Christian Elsaesser, Maryelle Kolopp, Danielle Roman

Biochem Pharmacol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of epithelial growth factor receptor (EGFR) kinase inhibitors on genetically reconstituted mouse mammary glands.
Daniel R Roth, Danielle Roman, Robert Cozens, Ralf Brandt, Wolfgang Seewald

Exp Toxicol Pathol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of low-dose valsartan and enalapril improves endothelial dysfunction and coronary reserve in Nomega-nitro-L-arginine methyl ester-treated spontaneously hypertensive rats.
Marc de Gasparo, Patrick Hess, Martine Clozel, Elke Persohn, Danielle Roman

J Cardiovasc Pharmacol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laser technologies in toxicopathology.
Danielle Roman, Brigitte Greiner, Merdol Ibrahim, Dominique Pralet, Paul-Georg Germann

Toxicol Pathol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laser technologies in toxicopathology.
Danielle Roman, Paul-Georg Germann

Exp Toxicol Pathol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis